
Altris Inc. is a MedTech company specializing in AI-powered solutions for ophthalmology and optometry, focusing on Optical Coherence Tomography (OCT) scan analysis. Their flagship product, Altris AI, is a standalone web platform that automates the detection of over 70 retina pathologies and biomarkers, improving diagnostic decision-making for eye care specialists. The platform is FDA cleared, CE certified, GDPR and HIPAA compliant, and compatible with all OCT devices. Altris AI is installed in more than 500 optometry centers and ophthalmic clinics worldwide, serving over 18,000 eye care professionals. The company also offers Altris Education OCT, a free mobile app used by 17,000+ ophthalmologists and optometrists for OCT education. Headquartered in Chicago with R&D centers in Kyiv and Malaga, Altris has established partnerships with major ophthalmic equipment manufacturers and continues to innovate with features like early glaucoma risk assessment and optic disc analysis. Their business model is primarily SaaS, targeting clinics and eye care professionals to enhance workflow efficiency, reduce errors, and enable early disease detection, positioning them as a leading AI company in eye care diagnostics.

Altris Inc. is a MedTech company specializing in AI-powered solutions for ophthalmology and optometry, focusing on Optical Coherence Tomography (OCT) scan analysis. Their flagship product, Altris AI, is a standalone web platform that automates the detection of over 70 retina pathologies and biomarkers, improving diagnostic decision-making for eye care specialists. The platform is FDA cleared, CE certified, GDPR and HIPAA compliant, and compatible with all OCT devices. Altris AI is installed in more than 500 optometry centers and ophthalmic clinics worldwide, serving over 18,000 eye care professionals. The company also offers Altris Education OCT, a free mobile app used by 17,000+ ophthalmologists and optometrists for OCT education. Headquartered in Chicago with R&D centers in Kyiv and Malaga, Altris has established partnerships with major ophthalmic equipment manufacturers and continues to innovate with features like early glaucoma risk assessment and optic disc analysis. Their business model is primarily SaaS, targeting clinics and eye care professionals to enhance workflow efficiency, reduce errors, and enable early disease detection, positioning them as a leading AI company in eye care diagnostics.
Headquarters: Chicago, Illinois
Product: Altris Image Management System (AI-powered OCT analysis, vendor-neutral)
Regulatory / Compliance: FDA 510(k) Class II cleared; CE certified; GDPR and HIPAA compliant
Customers / Reach: Installed in 500+ clinics; used by 18,000+ eye care professionals
Business Model: SaaS targeting clinics and eye care professionals
Ophthalmology / Optometry — automated analysis and management of Optical Coherence Tomography (OCT) scans for retinal disease detection and biomarker quantification.
2018
MedTech / Medical AI
Funding round announced June 1, 2024 and reported closed Dec 1, 2024; Crunchbase lists Network.VC and Digital Future among investors
“Investors include Network.VC and Digital Future; Crunchbase reports up to nine investors”